Lynne M. Laube's most recent trade in Nerdwallet Inc - Ordinary Shares - Class A was a trade of 18,137 Class A Common Stock done . Disclosure was reported to the exchange on May 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nerdwallet Inc (Class A) | Lynne M. Laube | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 18,137 | 60,133 | - | 0 | Class A Common Stock | |
| Nerdwallet Inc (Class A) | Lynne M. Laube | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 11,061 | 41,996 | - | 0 | Class A Common Stock | |
| Nerdwallet Inc (Class A) | Lynne M. Laube | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 15,120 | 30,935 | - | 0 | Class A Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 08 Nov 2022 | 4 | 313,547 (1%) | 0% | 4 | 16 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director | Sale of securities on an exchange or to another person at price $ 4.32 per share. | 07 Nov 2022 | 6,430 | 313,903 (1%) | 0% | 4.3 | 27,778 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director | Sale of securities on an exchange or to another person at price $ 3.99 per share. | 07 Nov 2022 | 352 | 313,551 (1%) | 0% | 4.0 | 1,403 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2022 | 14,062 | 0 | - | - | Performance Stock Unit | |
| Cardlytics Inc | Lynne M. Laube | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2022 | 14,062 | 320,333 (1%) | 0% | 0 | Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.19 per share. | 05 Aug 2022 | 6,612 | 306,271 (1%) | 0% | 15.2 | 100,436 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jun 2022 | 60,000 | 298,820 (1%) | 0% | 0 | Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2022 | 14,063 | 14,062 | - | - | Performance Stock Unit | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2022 | 14,063 | 312,883 (1%) | 0% | 0 | Common Stock | |
| Nerdwallet Inc (Class A) | Lynne M. Laube | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 15,815 | 15,815 | - | 0 | Class A Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 33.60 per share. | 05 May 2022 | 17,973 | 358,530 (1%) | 0% | 33.6 | 603,893 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2022 | 14,063 | 14,062 | - | - | Performance Stock Unit | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2022 | 14,063 | 376,503 (1%) | 0% | 0 | Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2022 | 6,622 | 362,440 (1%) | 0% | 0 | Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2022 | 6,622 | 19,868 | - | - | Restricted Stock Unit | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 20,161 | 355,818 (1%) | 0% | 0 | Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 20,161 | 40,322 | - | - | Restricted Stock Unit | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2022 | 63,233 | 63,293 | - | - | Restricted Stock Unit | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2022 | 2,766 | 335,657 (1%) | 0% | 0 | Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Mar 2022 | 1,112 | 332,891 (1%) | 0% | 0 | Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2021 | 56,250 | 56,250 | - | - | Performance Stock Unit | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2021 | 28,125 | 28,125 | - | - | Performance Stock Unit | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2021 | 28,125 | 351,593 (1%) | 0% | 0 | Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 68.63 per share. | 09 Dec 2021 | 7,432 | 339,617 (1%) | 0% | 68.6 | 510,058 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 67.62 per share. | 09 Dec 2021 | 4,544 | 347,049 (1%) | 0% | 67.6 | 307,265 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 69.36 per share. | 09 Dec 2021 | 1,100 | 338,517 (1%) | 0% | 69.4 | 76,296 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 90.23 per share. | 05 Nov 2021 | 10,676 | 325,781 (1%) | 0% | 90.2 | 963,295 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 92.95 per share. | 05 Nov 2021 | 911 | 323,467 (1%) | 0% | 92.9 | 84,677 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 92.26 per share. | 05 Nov 2021 | 800 | 324,378 (1%) | 0% | 92.3 | 73,808 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 90.88 per share. | 05 Nov 2021 | 603 | 325,178 (1%) | 0% | 90.9 | 54,801 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2021 | 56,250 | 56,250 | - | - | Performance Stock Unit | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2021 | 28,125 | 28,125 | - | - | Performance Stock Unit | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2021 | 28,125 | 336,457 (1%) | 0% | - | Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Sep 2021 | 4,000 | 334,003 (1%) | 0% | 0 | Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Sep 2021 | 514 | 338,003 (1%) | 0% | 0 | Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2021 | 3,376 | 44,025 | - | - | Employee Stock Option (Right to Buy) | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.00 per share. | 14 Jul 2021 | 3,376 | 311,708 (1%) | 0% | 20 | 67,520 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.00 per share. | 14 Jul 2021 | 2,138 | 310,470 (1%) | 0% | 20 | 42,760 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2021 | 2,138 | 41,887 | - | - | Employee Stock Option (Right to Buy) | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 123.77 per share. | 14 Jul 2021 | 1,976 | 309,732 (1%) | 0% | 123.8 | 244,570 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 124.56 per share. | 14 Jul 2021 | 1,100 | 308,632 (1%) | 0% | 124.6 | 137,016 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 124.95 per share. | 14 Jul 2021 | 700 | 308,432 (1%) | 0% | 125.0 | 87,465 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 123.03 per share. | 14 Jul 2021 | 638 | 309,132 (1%) | 0% | 123.0 | 78,493 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 122.29 per share. | 14 Jul 2021 | 400 | 309,770 (1%) | 0% | 122.3 | 48,916 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 120.42 per share. | 14 Jul 2021 | 300 | 310,170 (1%) | 0% | 120.4 | 36,126 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 125.77 per share. | 14 Jul 2021 | 300 | 308,332 (1%) | 0% | 125.8 | 37,731 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 125.56 per share. | 14 Jul 2021 | 100 | 308,332 (1%) | 0% | 125.6 | 12,556 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2021 | 5,424 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.32 per share. | 03 Jun 2021 | 5,424 | 313,756 (1%) | 0% | 8.3 | 45,128 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 101.52 per share. | 03 Jun 2021 | 4,775 | 309,971 (1%) | 0% | 101.5 | 484,758 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 102.65 per share. | 03 Jun 2021 | 1,539 | 308,432 (1%) | 0% | 102.6 | 157,978 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2021 | 990 | 48,301 | - | - | Employee Stock Option (Right to Buy) | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.00 per share. | 03 Jun 2021 | 990 | 314,746 (1%) | 0% | 20 | 19,800 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2021 | 900 | 47,401 | - | - | Employee Stock Option (Right to Buy) | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 100.67 per share. | 03 Jun 2021 | 900 | 308,332 (1%) | 0% | 100.7 | 90,603 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.00 per share. | 03 Jun 2021 | 900 | 309,232 (1%) | 0% | 20 | 18,000 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 103.16 per share. | 03 Jun 2021 | 100 | 308,332 (1%) | 0% | 103.2 | 10,316 | Common Stock |